News & Articles

Discover how collaborative research between big pharma and academia is using the latest proteomics platforms to revolutionize drug discovery

Catch up on this expert webinar to discover the customizable screening service helping to drive the validation of novel cancer therapies

In this guest editorial, explore how artificial intelligence is becoming a powerful tool for drug discovery

Infectious disease expert shares how robust LC columns are facilitating the analysis of complex pathogen samples

Dr. Raul Cano, Chief Scientific Officer at The BioCollective, discusses how to increase sequencing data accuracy and reproducibility and the future of the microbiome in healthcare

The growing heart failure pandemic increases need for new innovative assays

Keep up to date with the latest research and discover the tools and techniques advancing 3D cell culture and its applications

Pushing the spatial genomics frontier one biomolecule at a time from RNA to DNA

In this guest editorial, Fritz Gyger AG shares how the revolutionary Droplet Microarray provides a solution to the limitations currently faced when using traditional microplates

The new emerging variant panel add-on for use with existing CleanPlex SARS-CoV-2 products allows researchers to easily maintain confident variant identification as the virus evolves

The test offers 98.0% clinical sensitivity for samples with PCR Ct values up to 31

CRAIC TimePro software can be used with CRAIC Technologies microspectrometers to measure the kinetic UV-visible-NIR and fluorescence spectra of microscopic sample areas

The assays will help public health researchers track SARS-CoV-2 variants more rapidly and cost-effectively

The ZEISS Axioscan 7 combines scanning performance with application freedom

JEOL and SOQUELEC have a long relationship dating back to the 1970s

The addition of the PyroWave XM Fluorescent Reader complements the existing absorbance readers used in traditional LAL-based assays

Guest editorial: Brice Ezzouaouy, Senior Product Manager, Beckman Coulter Life Sciences, outlines the challenges of dimly expressed markers and presents a solution